Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
11 p, 572.5 KB Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients : a position statement from an international expert group / Mohty, M. (Hematology Department. AP-HP. Hôpital Saint-Antoine. Sorbonne Université) ; Malard, F. (Hematology Department. AP-HP. Hôpital Saint-Antoine. Sorbonne Université) ; Abecasis, M. (Instituto Portugues de Oncologia) ; Aerts, E. (Department of Internal Medicine-Oncology. University Hospital Zurich) ; Alaskar, A.S. (Department of Oncology. King Abdulaziz Medical City. King Abdullah International Medical Research Center. King Saud Bin Abdulaziz University for Health Sciences. Ministry of National Guard Health Affairs) ; Aljurf, M. (King Faisal Specialist Hospital and Research Centre) ; Arat, M. (HSCT Unit. Sisli Florence Nightingale Hospital) ; Bader, P. (Division for Stem Cell Transplantation and Immunology. Department for Children and Adolescents. University Hospital. Goethe University) ; Baron, F. (Department of Hematology. University of Liege) ; Basak, G. (Medical University of Warsaw) ; Bazarbachi, A. (Department of Internal Medicine. American University of Beirut) ; Blaise, D. (Transplant and Cellular Immunotherapy Program. Department of Hematology. Aix-Marseille Univ. Inserm. CNRS. Institut Paoli-Calmettes. CRCM) ; Ciceri, F. (Hematology and Bone Marrow Transplantation Unit. IRCCS Ospedale San Raffaele. University Vita-Salute) ; Corbacioglu, S. (Department of Pediatric Hematology. Oncology and Stem Cell Transplantation. University of Regensburg) ; Dalle, J.H. (Department of Hematology and Immunology. Hospital Robert Debre. Paris 7-Paris Diderot University) ; Dignan, F. (Department of Clinical Haematology. Central Manchester Foundation Trust) ; Fukuda, T. (HSCT Division. National Cancer Center Hospital) ; Huynh, A. (Hematology Department. Institut Universitaire du Cancer Toulouse-Oncopole) ; Kuball, J. (Department of Haematology. University Medical Centre) ; Lachance, S. (Department of Hematology and Stem Cell Transplant Program. Hôpital Maisonneuve-Rosemont. University of Montreal) ; Lazarus, H. (Case Western Reserve University) ; Masszi, T. (Department of Hematology and Stem Cell Transplantation. St. Istvan and St. Laszlo Hospital. Budapest 3 Department of Internal Medicine. Semmelweis University) ; Michallet, M. (Hematology Department. Groupement Hospitalier Sud. Hospices Civils de Lyon. Université Claude Bernard Lyon EST) ; Nagler, A. (Hematology and Bone Marrow Transplantation. Chaim Sheba Medical Center) ; NiChonghaile, M. (National Stem Cell Transplant Unit (Adults). Department of Haematology. St James's Hospital and Academic Department of Haematology. Trinity College Dublin) ; Okamoto, S. (Division of Hematology. Department of Medicine. Keio University School of Medicine) ; Pagliuca, A. (Department of Haematological Medicine. King's College Hospital) ; Peters, C. (Department of Pediatrics. St. Anna Kinderspital) ; Petersen, F.B. (LDS Hospital) ; Richardson, P.G. (Division of Hematology. Mayo Clinic) ; Ruutu, T. (Clinical Research Institute. Helsinki University Hospital) ; Saber, W. (Center for International Blood and Marrow Transplant Research. Medical College of Wisconsin) ; Savani, B.N. (Hematology and Stem Cell Transplantation Section. Division of Hematology/Oncology. Department of Medicine. Vanderbilt University Medical Center and Veterans Affairs Medical Center) ; Soiffer, R. (Division of Hematologic Malignancies. Dana-Farber Cancer Institute) ; Styczynski, J. (Pediatric Hematology and Oncology. University Hospital. Collegium Medicum UMK) ; Wallhult, E. (Section of Haematology and Coagulation. Department of Internal Medicine. Sahlgrenska University Hospital) ; Yakoub-Agha, I. (CHU de Lille. LIRIC INSERM U995. Université de Lille2) ; Duarte, R.F. (Department of Hematology. Hospital Universitario Puerta de Hierro Majadahonda) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
2020 - 10.1038/s41409-019-0705-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 485-495  
2.
8 p, 788.7 KB A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) / Hájek, R. (University Hospital Ostrava) ; Masszi, T (St István and St László Hospital of Budapest) ; Petrucci,M.T. (Sapienza Università di Roma) ; Palumbo, A. (Università di Torino) ; Rosiñol, L. (Hospital Clínic i Provincial de Barcelona) ; Nagler, Arnon. (Chaim Sheba Medical Center (Israel)) ; Yong, K.L. (University College London Cancer Institute) ; Oriol, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Minarik, J. (University Hospital Olomouc and Medical Faculty of Palacky) ; Pour, L (University Hospital Ostrava) ; Dimopoulos, M.A. (National and Kapodistrian University of Athens) ; Maisnar, V. (Charles University Teaching Hospital, Hradec Králové) ; Rossi, D. (Amedeo Avogadro University of Eastern Piedmont) ; Kasparu, H. (Hospital Elisabethinen Linz) ; Van Droogenbroeck, J. (AZ Sint-Jan, Brugge, Belgium) ; Yehuda, D.B. (Hadassah Medical Center, Jerusalem, Israel) ; Hardan, I. (Meir Medical Center, Kfar-Saba, Israel) ; Jenner, M. (Southampton General Hospital, Hampshire, UK) ; Calbecka, M. (Nicolaus Copernicus Hospital, Toruń Poland) ; Dávid, M. (University of Pécs, Hungary) ; de la Rubia, J. (Hospital Universitario La Fe, València) ; Drach, J. (Medical University of Vienna) ; Gasztonyi, Z. (Petz Aladár Megyei Oktató Kórház, Vasvári Pál, Hungary) ; Górnik, S. (Zamojski Szpital Niepubliczny, Zamosc, Poland) ; Leleu, X. (Hopital Huriez, CHRU, Lille, France) ; Munder, M. (University Medicine Mainz, Germany) ; Offidani, M (Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Italy) ; Zojer, N. (Center for Oncology, Hematology with Outpatient Department and Palliative Care, Wilhelminenspital, Vienna, Austria) ; Rajangam, K. (Onyx Pharmaceuticals, Inc.) ; Chang, Y.L. (Onyx Pharmaceuticals, Inc.) ; San-Miguel, J.F. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Ludwig, H. (Wilhelminen Cancer Research Institute, Vienna, Austria)
This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). [...]
2017 - 10.1038/leu.2016.176
Leukemia, Vol. 31 (2017) , p. 107-114  

Vegeu també: autors amb noms similars
1 Masszi, T
1 Masszi, T.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.